The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad

Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.

Bibliographic Details

Published in:	Indian Journal of Medical and Paediatric Oncology
Main Author:	Sandip A Shah
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2013-01-01
Subjects:	Chronic myeloid leukemia Gujarat cancer and research institute imatinib
Online Access:	http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=189;epage=192;aulast=Shah